ClinVar Miner

Submissions for variant NM_000518.5(HBB):c.93-3T>G (rs34527846)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000030011 SCV000052666 pathogenic beta Thalassemia 2016-05-09 criteria provided, single submitter clinical testing Variant summary: The HBB c.93-3T>G variant affects a conserved intronic nucleotide close to the consensus splice acceptor site. MutationTaster predicts damaging outcome for this variant. In addition, 3/5 splice-tools in Alamut predict that this variant to affect normal splicing. This variant is found in 1/122554 control chromosomes including the large and broad population of ExAC at a frequency of 0.0000082, which does not exceed the estimated maximal expected frequency of a pathogenic allele (0.0111803) in this gene. In literature, this variant is widely regarded as a variant that causes BTHAL ITMD with consistent patient/family data. Taken together, this variant has been classified as pathogenic.
The ITHANET community portal, The Cyprus Institute of Neurology and Genetics RCV000030011 SCV001244584 pathogenic beta Thalassemia 2019-11-25 no assertion criteria provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.